Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.

Oliveira CR, Paredes-Gamero EJ, Barbosa CM, Nascimento FD, Batista EC, Reis FC, Martins AH, Ferreira AT, Carmona AK, Pesquero JB, Tersariol IL, Araújo RC, Bincoletto C.

Chem Biol Interact. 2010 Mar 30;184(3):388-95. doi: 10.1016/j.cbi.2010.01.015. Epub 2010 Jan 22.

PMID:
20096676
2.

Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.

Azizi M, Junot C, Ezan E, Ménard J.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1066-9.

PMID:
11903317
4.

Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system.

Yosipiv IV, Dipp S, El-Dahr SS.

Am J Physiol Renal Physiol. 2001 Nov;281(5):F795-801.

5.
6.

Disruption of the kinin B1 receptor gene affects potentiating effect of captopril on BK-induced contraction in mice stomach fundus.

Barbosa AM, Felipe SA, Pesquero JB, Paiva AC, Shimuta SI.

Peptides. 2006 Dec;27(12):3377-82. Epub 2006 Oct 31.

PMID:
17079052
7.
8.

Hemodynamic and renal involvement of B1 and B2 kinin receptors during the acute phase of endotoxin shock in mice.

Seguin T, Buleon M, Destrube M, Ranera MT, Couture R, Girolami JP, Tack I.

Int Immunopharmacol. 2008 Feb;8(2):217-21. doi: 10.1016/j.intimp.2007.08.008. Epub 2007 Aug 31.

PMID:
18182230
10.
11.

In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide.

Comte L, Lorgeot V, Bignon J, Volkov L, Dupuis F, Wdzieczak-Bakala J, Praloran V.

Eur J Clin Invest. 1998 Oct;28(10):856-63.

PMID:
9793000
12.

Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures.

Chisi JE, Wdzieczak-Bakala J, Thierry J, Briscoe CV, Riches AC.

Stem Cells. 1999;17(6):339-44.

14.
15.

Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans.

Azizi M, Ezan E, Reny JL, Wdzieczak-Bakala J, Gerineau V, Ménard J.

Hypertension. 1999 Mar;33(3):879-86.

17.
18.
19.

Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.

Bonnet D, Lemoine FM, Khoury E, Pradelles P, Najman A, Guigon M.

Exp Hematol. 1992 Nov;20(10):1165-9.

PMID:
1385195
20.

Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.

Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S.

Invest Ophthalmol Vis Sci. 2007 May;48(5):2321-6.

PMID:
17460297

Supplemental Content

Support Center